Compare Enzyme (MLN) vs Neuron (NRN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Neuron — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Neuron trades at Rp63.99 (market cap Rp26,48M, Rp841,43jt 24h volume). The key difference: Enzyme is far larger — about 5.1× Neuron's market cap, and Neuron's supply is capped (358,6M / 1B NRN (36%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Neuron for 11 Days on average.
| MLN | NRN | |
|---|---|---|
Market Cap | Rp134,13M | Rp26,48M |
Volume (24h) | Rp104,56M | Rp841,43jt |
Circulating Supply | 3,3M MLN | 358,6M / 1B NRN (36%) |
Typical Hold Time | 29 Days | 11 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Neuron (NRN) presents a unique case with a very low market cap of Rp26.48M and a circulating supply of 358.6jt tokens (36% of max supply), indicating a nascent stage. The average hold time of 11 days suggests active, short-term trading. Without a current price, technical analysis is limited, but the asset's micro-cap status implies high volatility and liquidity risk. No recent protocol updates or ecosystem news were identified, pointing to low current development activity.
Overall outlook is highly speculative due to the token's small size and lack of recent developments. The primary opportunity lies in potential future ecosystem growth from its early stage. Major risks include extreme price volatility, low liquidity making entry/exit difficult, and the high chance of price manipulation. Investors should approach with caution and only allocate risk capital.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Neuron
NRN is developing an ecosystem aimed at accelerating the journey toward Artificial General Intelligence (AGI), using Gaming and robotics as experimental platforms. At its core is NRN Agents, a platform that facilitates the integration of AI agents within advanced Gaming experiences in both virtual and physical environments. The technology stack combines data aggregation, model training, and model inspection, utilizing both imitation learning and reinforcement learning to advance AI development.
Read more on NRN →
